The Study: Real-World Weight Loss Outcomes Researchers analyzed data from over 50,000 adults with obesity: 38,545 patients received a GLP-1 medication such as semaglutide or tirzepatide 12,540 patients underwent bariatric surgery, primarily gastric bypass or sleeve gastrectomy Key Findings : Surgery patients lost an average of 24% of their body weight over two years about 58 pounds
At 200mg weekly testosterone, aromatase inhibitor use is typically unnecessary for most men
Medications like Ozempic (semaglutide), Wegovy (higher dose of semaglutide), Mounjaro, and Zepbound (tirzepatide) mimic this hormone, sending signals to your brain that increase feelings of fullness and satisfaction
The manufacturer sets wholesale pricing uniformly, and while individual pharmacies might add different markups, these variations are modest
Figures and comparison tables of GLP-1RAs provide valuable insights into dosing frequency, main use, weight loss efficacy, and blood sugar control, assisting healthcare professionals and patients in choosing the most appropriate treatment based on therapeutic goals and individual needs
However, some doctors say lower doses may be considered for people seeking more modest weight loss, too
